Focuses on genetic abnormalities that occur in transcriptional control elements in cases of acute myeloid leukemia (AML). Transcriptional regulatory element in which mutations have been identified in AML; Role of CCAAT-enhancer binding protein alpha (C/EBP-α) protein in normal granulocytic differentiation; Mutations in C/EBP-α.